Expression of connective tissue growth factor in cartilaginous tumors.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMID 11013359)

Published in Cancer on October 01, 2000

Authors

T Shakunaga1, T Ozaki, N Ohara, K Asaumi, T Doi, K Nishida, A Kawai, T Nakanishi, M Takigawa, H Inoue

Author Affiliations

1: Department of Orthopaedic Surgery, Faculty of Medicine, Okayama University Medical School, Okayama, Japan.

Articles citing this

NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol (2001) 3.27

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Metastasis Rev (2010) 1.92

A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis. Cancer Cell Int (2003) 1.65

The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Cancer Res (2009) 1.64

Glioma cells on the run - the migratory transcriptome of 10 human glioma cell lines. BMC Genomics (2008) 1.28

Novel transcription-factor-like function of human matrix metalloproteinase 3 regulating the CTGF/CCN2 gene. Mol Cell Biol (2008) 1.19

The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis. Histol Histopathol (2010) 1.11

Regional assessment of articular cartilage gene expression and small proteoglycan metabolism in an animal model of osteoarthritis. Arthritis Res Ther (2005) 1.10

Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2. Mol Cancer Res (2008) 1.06

Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme. Int J Cancer (2010) 1.04

CTGF is a therapeutic target for metastatic melanoma. Oncogene (2013) 1.00

Connective tissue growth factor is required for normal follicle development and ovulation. Mol Endocrinol (2011) 0.96

Vascular endothelial growth factor in salivary pleomorphic adenomas: one of the reasons for their poorly vascularized stroma. Virchows Arch (2005) 0.95

Expression of connective tissue growth factor (CCN2) in desmoplastic small round cell tumour. J Clin Pathol (2004) 0.94

Targeting connective tissue growth factor (CTGF) in acute lymphoblastic leukemia preclinical models: anti-CTGF monoclonal antibody attenuates leukemia growth. Ann Hematol (2013) 0.93

Connective tissue growth factor in tumor pathogenesis. Fibrogenesis Tissue Repair (2012) 0.91

Gene expression of connective tissue growth factor (CTGF/CCN2) in calcifying tissues of normal and cbfa1-null mutant mice in late stage of embryonic development. J Bone Miner Metab (2005) 0.91

CCN2 enhances resistance to cisplatin-mediating cell apoptosis in human osteosarcoma. PLoS One (2014) 0.90

Chondrosarcoma and peroxisome proliferator-activated receptor. PPAR Res (2008) 0.89

Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review). Int J Mol Med (2015) 0.88

Microenvironment alters epigenetic and gene expression profiles in Swarm rat chondrosarcoma tumors. BMC Cancer (2010) 0.86

LC3-mediated fibronectin mRNA translation induces fibrosarcoma growth by increasing connective tissue growth factor. J Cell Sci (2009) 0.85

Microrna-199a-5p Functions as a Tumor Suppressor via Suppressing Connective Tissue Growth Factor (CTGF) in Follicular Thyroid Carcinoma. Med Sci Monit (2016) 0.81

Collapsin response mediator proteins: Potential diagnostic and prognostic biomarkers in cancers (Review). Oncol Lett (2014) 0.80

Connective tissue growth factor inhibits gastric cancer peritoneal metastasis by blocking integrin α3β1-dependent adhesion. Gastric Cancer (2014) 0.77

Molecular mechanisms of peritoneal dissemination in gastric cancer. World J Gastroenterol (2016) 0.75

Potential for modulation of the fas apoptotic pathway by epidermal growth factor in sarcomas. Sarcoma (2011) 0.75

CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK/MEK/ERK signal pathway in colorectal cancer. Onco Targets Ther (2016) 0.75

Articles by these authors

'Green mice' as a source of ubiquitous green cells. FEBS Lett (1997) 17.06

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell (1996) 15.19

A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature (1997) 5.55

Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's. Science (1989) 5.08

An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell (2001) 4.41

Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med (1996) 4.27

ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol (1994) 4.09

Sub-piconewton force fluctuations of actomyosin in vitro. Nature (1991) 3.89

A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization. Cell (1989) 3.70

The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J Biol Chem (1986) 3.64

Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature (1987) 3.55

Synthesis and hybridization studies on two complementary nona(2'-O-methyl)ribonucleotides. Nucleic Acids Res (1987) 3.24

TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol (1985) 3.18

EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol (1998) 3.10

Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet (1998) 3.01

Logic circuits with carbon nanotube transistors. Science (2001) 2.98

A novel NMR method for determining the interfaces of large protein-protein complexes. Nat Struct Biol (2000) 2.86

Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol (1999) 2.77

Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol (1999) 2.77

Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and RNase H. FEBS Lett (1987) 2.74

Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics (1993) 2.67

The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology (1984) 2.65

Site-directed cleavage of RNA. Nucleic Acids Res (1987) 2.53

Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro. J Biol Chem (1999) 2.49

Studies on nucleic acid interactions. I. Stabilities of mini-duplexes (dG2A4XA4G2-dC2T4YT4C2) and self-complementary d(GGGAAXYTTCCC) containing deoxyinosine and other mismatched bases. Nucleic Acids Res (1986) 2.49

Recanalization after coil embolotherapy of pulmonary arteriovenous malformations: study of long-term outcome and mechanism for recanalization. AJR Am J Roentgenol (1998) 2.38

Divergence and convergence of TGF-beta/BMP signaling. J Cell Physiol (2001) 2.37

The FHIT gene 3p14.2 is abnormal in lung cancer. Cell (1996) 2.36

c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. J Biol Chem (1999) 2.32

The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters. J Biol Chem (1987) 2.25

Activation of the ERK/MAPK pathway by an isoform of rap1GAP associated with G alpha(i) Nature (1999) 2.23

Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J (1998) 2.20

Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem (1999) 2.18

Identification of the amino acid residues involved in an active site of Escherichia coli ribonuclease H by site-directed mutagenesis. J Biol Chem (1990) 2.12

Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet (2000) 2.08

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest (2001) 2.07

Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res (1995) 2.07

NMR studies of a DNA containing 8-hydroxydeoxyguanosine. Nucleic Acids Res (1991) 2.03

Magnifying endoscopy, stereoscopic microscopy, and the microvascular architecture of superficial esophageal carcinoma. Endoscopy (2002) 2.01

Proposal for a unified CCN nomenclature. Mol Pathol (2003) 1.98

Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res (2001) 1.98

Percutaneous radiofrequency ablation in osteoid osteoma. J Bone Joint Surg Br (2001) 1.97

Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am J Physiol (1995) 1.93

Role of Gab1 in heart, placenta, and skin development and growth factor- and cytokine-induced extracellular signal-regulated kinase mitogen-activated protein kinase activation. Mol Cell Biol (2000) 1.92

Solid tumors after heart transplantation: lethality of lung cancer. Ann Thorac Surg (1995) 1.92

Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses. Immunity (2000) 1.92

Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDIalpha. Oncogene (1999) 1.91

Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma. Diagn Mol Pathol (2000) 1.91

Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem (1998) 1.87

WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum Mol Genet (2001) 1.86

Characterization of DNA polymerase from Pyrococcus sp. strain KOD1 and its application to PCR. Appl Environ Microbiol (1997) 1.86

Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro. J Clin Invest (1994) 1.85

Negative control of replication initiation by a novel chromosomal locus exhibiting exceptional affinity for Escherichia coli DnaA protein. Genes Dev (1998) 1.85

Constitutive activation of NF-kappa B is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. EMBO J (1996) 1.85

Routine endoscopy using a magnifying endoscope for gastric cancer diagnosis. Endoscopy (2002) 1.84

Distribution of IgG subclasses in membranous nephropathy. Clin Exp Immunol (1984) 1.82

Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat Med (1999) 1.82

Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82

Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update (2004) 1.81

Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye. Br J Ophthalmol (1997) 1.80

Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J Clin Invest (1990) 1.79

Rapid disease progression correlates with instability of mutant SOD1 in familial ALS. Neurology (2005) 1.78

Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res (1997) 1.76

Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews. Hum Mol Genet (1996) 1.76

Dysfunction of human Rad18 results in defective postreplication repair and hypersensitivity to multiple mutagens. Proc Natl Acad Sci U S A (2000) 1.74

Exercise-induced U-wave alterations as a marker of well-developed and well-functioning collateral vessels in patients with effort angina. J Am Coll Cardiol (2000) 1.73

EML4-ALK fusion transcript is not found in gastrointestinal and breast cancers. Br J Cancer (2008) 1.73

Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene. Nat Genet (2000) 1.71

Characteristics of the human ocular surface epithelium. Prog Retin Eye Res (2001) 1.71

Duodenal somatostatinoma: a case report and review of 31 cases with special reference to the relationship between tumor size and metastasis. Pathol Int (2000) 1.70

Prolonged carbon dioxide insufflation under general anesthesia for endoscopic submucosal dissection. Endoscopy (2010) 1.68

Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers. Biochem Biophys Res Commun (2001) 1.67

Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase. Mol Cell Biol (1998) 1.66

Granular corneal dystrophy with homozygous mutations in the kerato-epithelin gene. Am J Ophthalmol (1998) 1.66

Cloning of an amino acid transporter with functional characteristics and tissue expression pattern identical to that of system A. J Biol Chem (2000) 1.66

Characterization of a bone morphogenetic protein-responsive Smad-binding element. Mol Biol Cell (2000) 1.66

Amino acid sequence of mammalian elongation factor 2 deduced from the cDNA sequence: homology with GTP-binding proteins. Proc Natl Acad Sci U S A (1986) 1.64

Total synthesis of a RNA molecule with sequence identical to that of Escherichia coli formylmethionine tRNA. Proc Natl Acad Sci U S A (1981) 1.63

A eukaryotic gene encoding an endonuclease that specifically repairs DNA damaged by ultraviolet light. EMBO J (1995) 1.63

Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci U S A (2001) 1.63

Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system. Cell Mol Life Sci (1998) 1.62

Creutzfeldt-Jakob disease with florid plaques after cadaveric dural graft in a Japanese woman. Lancet (1997) 1.60

Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res (1995) 1.60

Synthesis and properties of novel nucleic acid probes. Nucleic Acids Symp Ser (1985) 1.60

Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection. Endoscopy (2005) 1.60

Scanning electron microscopy of normal and rheumatoid articular cartilages. Arch Histol Jpn (1969) 1.59

Non-traumatic paralysis of the posterior interosseous nerve. J Bone Joint Surg Br (1996) 1.59

Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma. Br J Cancer (2005) 1.59

Identification of the gene responsible for gelatinous drop-like corneal dystrophy. Nat Genet (1999) 1.59

Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells. J Biol Chem (2000) 1.58

Spontaneous autoimmune skin lesions of MRL/n mice: autoimmune disease-prone genetic background in relation to Fas-defect MRL/1pr mice. J Invest Dermatol (1996) 1.57

A new simplified technique of endoscopic esophageal mucosal resection using a cap-fitted panendoscope (EMRC) Surg Endosc (1993) 1.57

Detection of herpes simplex virus DNA in human tear film by the polymerase chain reaction. Am J Ophthalmol (1994) 1.57

Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture. Endocrinology (2000) 1.57

Fractal character of the neural spike train in the visual system of the cat. J Opt Soc Am A Opt Image Sci Vis (1997) 1.56

Phlebosclerosis of the colon with positive anti-centromere antibody. Intern Med (1999) 1.55

In vivo self-renewal of c-Kit+ Sca-1+ Lin(low/-) hemopoietic stem cells. J Immunol (1996) 1.55